Nuvectis Pharma (NVCT) Shares Issued (2021 - 2026)

Nuvectis Pharma (NVCT) reported Shares Issued of $348281.0 for Q1 2026, up 4.5% on a YoY basis from $333281.0 in Q1 2025, and little changed sequentially from $348281.0 in Q4 2025.

Nuvectis Pharma (NVCT) Shares Issued (2021 - 2026) Analysis & Trends

Nuvectis Pharma (NVCT) has 6 years of Shares Issued data on file, last reported at $348281.0 in Q1 2026.

  • For the quarter ending Q1 2026, Shares Issued rose 4.5% year-over-year to $348281.0; the trailing twelve-month figure through Mar 2026 stood at $348281.0 (up 4.5% YoY), and the FY2025 full-year result was $348281.0, changed 0.0% from the prior year.
  • Shares Issued held at $348281.0 in Q1 2026, from $348281.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1.2 million in Q1 2024 to a low of $21000.0 in Q2 2023.
  • A 5-year average of $357568.4 and a median of $348281.0 in 2023 frame the typical range for Shares Issued.
  • Across the five-year window, Shares Issued tumbled 92.92% in 2023 and soared 1558.48% in 2024, its largest moves.
  • Tracing NVCT's Shares Issued over 5 years: stood at $338807.0 in 2022, then gained by 2.8% to $348281.0 in 2023, then changed by 0.0% to $348281.0 in 2024, then changed by 0.0% to $348281.0 in 2025, then changed by 0.0% to $348281.0 in 2026.
  • Business Quant data shows NVCT's Shares Issued at $348281.0 in Q1 2026, $348281.0 in Q4 2025, and $348281.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 19.44 Mn
10 Nuvectis Pharma 471.80 Mn 471.80 Mn - 348,281.00

Historic Data

Download Data
DateValue
Mar 31, 2026 348,281.00
Mar 31, 2026 348,281.00
Dec 31, 2025 348,281.00
Dec 31, 2025 348,281.00
Sep 30, 2025 348,281.00
Sep 30, 2025 348,281.00
Jun 30, 2025 348,281.00
Jun 30, 2025 348,281.00
Mar 31, 2025 333,281.00
Mar 31, 2025 333,281.00
Dec 31, 2024 348,281.00
Dec 31, 2024 348,281.00
Sep 30, 2024 348,281.00
Sep 30, 2024 348,281.00
Jun 30, 2024 348,281.00
Jun 30, 2024 348,281.00
Mar 31, 2024 1.17 Mn
Mar 31, 2024 1.17 Mn
Dec 31, 2023 348,281.00
Dec 31, 2023 348,281.00